MktsMarkets

Immunic, Inc.
NASDAQ: IMUXKey statistics
IMUX News
Stories mentioning IMUX from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 25,626 | 19,069 | 20,012 | 21,369 | 21,533 | 21,617 | 21,370 | 18,323 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 33,235 | 23,327 | 25,993 | 27,083 | 26,825 | 25,631 | 25,726 | 22,814 |
| Operating Income (Loss) | (33,235) | (23,327) | (25,993) | (27,083) | (26,825) | (25,631) | (25,726) | (22,814) |
| Interest Income | 760.00 | 197.00 | 419.00 | 241.00 | 183.00 | 429.00 | 776.00 | 998.00 |
| Interest Expense | ||||||||
| Other Expense | (113.00) | 3,830 | (5.00) | 22.00 | 1,169 | 27.00 | 582.00 | 436.00 |
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (32,588) | (19,300) | (25,579) | (26,820) | (25,473) | (25,175) | (24,368) | (21,380) |
| Earnings Per Share (Basic) | (1.08) | (0.12) | (0.13) | (0.20) | (2.51) | (0.25) | (0.24) | (0.21) |
| Earnings Per Share (Diluted) | (1.08) | (0.12) | (0.13) | (0.20) | (2.51) | (0.25) | (0.24) | (0.21) |
| Weighted Average Shares Outstanding (Basic) | 30,136 | 155,688 | 193,898 | 132,175 | 10,134 | 100,175 | 101,273 | 101,273 |
| Weighted Average Shares Outstanding (Diluted) | 30,136 | 155,688 | 193,898 | 132,175 | 10,134 | 100,175 | 101,273 | 101,273 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About IMUX
Immunic, Inc. (NASDAQ: IMUX) is a stock listed on the Nasdaq Stock Market under the ticker symbol IMUX. It last traded at $6.97 (Oct 16, 2026, 4:00 PM ET), down 1.8% on the day. That gives Immunic a market capitalisation of $95.1M.
Over the past 52 weeks IMUX has traded between $5.06 and $17.43.
For the quarter ended Mar 31, 2026 it reported a net loss of $32.6M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$32.6M |
| Dec 31, 2025 | — | -$19.3M |
| Sep 30, 2025 | — | -$25.6M |
| Jun 30, 2025 | — | -$26.8M |
From Immunic’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…